Large Volume Wearable Injectors Market by Roots Analysis

Over the years, a rise in preference for self-administrable drugs / therapies has resulted in an increasing demand for user-friendly drug delivery solutions that are not only safe and efficient, but also promote therapy adherence

London

Roots Analysis has announced the addition of “Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices” report to its list of offerings.

The wide-spread prevalence of chronic diseases has compelled drug developers to innovate and design better, more advanced healthcare solutions. Large volume wearable injectors were developed to specifically address certain challenges associated with the administration of high volume formulations, viscous drug solutions and cater to frequent dosing requirements of patients suffering from chronic health conditions.

To order this 500+ page report, which features 175+ figures and 200+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html

Key Market Insights

More than 25 large volume wearable injectors are presently available / under development for the administration of drugs, excluding insulin
Over 45% of the abovementioned devices are capable of delivering bolus doses, followed by devices designed for continuous dosing at pre-programmed rates (15 %). These devices are powered by a diverse variety of actuation mechanisms, including rotary pumps, cells / expanded batteries, springs, osmotic pressure and liquefied gas. It is worth noting that over 15+ known drug-device combinations are commercialized / under development.

Leave a Reply

Your email address will not be published. Required fields are marked *